Lesley Stolz

last updated 1/20/2018

Lesley A. Stolz

Executive Vice President Corporate Development at BioTime , Inc.

Location:
1010 Atlantic Avenue Suite 102, Alameda, California, United States
HQ Phone:
(510) 521-3390

General Information

Experience

Vice President Business Development - Sutro Biopharma Inc

Senior Director, Business Development - GPC Biotech AG

Senior Director, Business Development - Aerovance , Inc.

Director, Business Development - Cell Genesys , Inc.

Technology Manager - BIACORE

Education

B.S.University of Virginia

M.S. degreesUniversity of Rochester

Ph.D.University of Rochester

Ph.D. - organic chemistry , Harvard Medical School

Affiliations

Board of Trustees - LES

Trustee, Meeting Content - Johnson & Johnson Innovations

Recent News  

2013 Press Releases | Investors & Media | BioTime, Inc.

BioTime Announces the Appointment of Lesley Stolz as Executive Vice President of Corporate Development
ALAMEDA, Calif.--(BUSINESS WIRE)--Aug. 21, 2013-- BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced the expansion of its senior management team with the appointment of Lesley Stolz, Ph.D. as Executive Vice President, Corporate Development. Dr. Stolz has more than 18 years of life science industry experience in corporate and business development. ...

Read More
Asterias Biotherapeutics - A Global Leader In Regenerative Medicine

Lesley Stolz, Ph.D., 510-521-3390, ext. 367
Executive Vice President, Corporate Development lstolz@biotimemail.com

Read More
BioTime's management team and its extensive experience in Stem Cell Biotechnology

Headshot of Lesley Stolz
Lesley Stolz, Ph.D. Executive Vice President, Corporate Development Dr. Stolz became our Executive Vice President, Corporate Development in August of 2013. She has 17 years of business and corporate development experience working for companies that are both technology platform and therapeutics focused. She was most recently Vice President Business Development at Sutro Biopharma, Inc. where she was responsible for all aspects of collaborations as well as fund raising during a three year period where the company entered into strategic collaborations and completed a significant Series C raise of $36.5M. Prior to Sutro Biopharma, Inc, she was with Sunesis Pharmaceuticals where she was Vice President of Corporate Business Development. Earlier in her career, she served as Senior Director, Business Development for Aerovance, Inc. where she led efforts to partner the company's Phase 2 asset for uncontrolled asthma. Lesley was Senior Director, Business Development for GPC Biotech AG of Germany from 2002 to 2006. She also served in senior management positions at Cell Genesys, Discovery Partners International and Axys Pharmaceuticals. Dr. Stolz received her Ph.D. in chemistry, and conducted postdoctoral research at Harvard Medical School's Department of Biochemistry and Molecular Pharmacology.

Read More

Browse ZoomInfo’s Directories